Apogee Therapeutics Inc
(NAS:APGE)
$
134.17
-0.14 (-0.1%)
Market Cap: 10.15 Bil
Enterprise Value: 9.10 Bil
PE Ratio: 0
PB Ratio: 8.00
GF Score: 12/100 Apogee Therapeutics Inc at Citi Global Healthcare Conference Transcript
Dec 03, 2025 / 02:45PM GMT
Release Date Price:
$74.55
(+7.84%)
Geoffrey Meacham
Citigroup - Analyst
The second day of the Citi Global Healthcare Conference. So I'm Geoff Meacham. I'm the senior biopharma analyst. My team here too, Nishant, Ross, Mary Kate.
So we're thrilled to have Apogee with us. So we have Jane Henderson, CFO. We have Jeff Hartness, CCO. So guys, thanks for joining us. Good to see you.
Jane Henderson
Apogee Therapeutics Inc - Chief Financial Officer
Thank you, Geoff.
Jeff Hartness
Apogee Therapeutics Inc - Chief Commercial Officer
Good to see you as well.
Geoffrey Meacham
Citigroup - Analyst
So we have some questions, but do you want to like kind of give maybe a quick summary? Or do you want to get ready into questions? It's totally up to you.
Jane Henderson
Apogee Therapeutics Inc - Chief Financial Officer
I can give a very quick summary. First of all, thank you for having us. We're really pleased to be here and look forward to a robust discussion. 2026
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot